Connect with us
Awakn will also partner with Charnwood Discovery to help it synthesize the new compounds for further testing. Canadian biotech firm Awakn Life Sciences Corp. (CSE: AWKN)...
Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) released its financial results for the first quarter ending June 30, 2024. Red Light‘s revenue grew from last...
An administrative law judge with the Drug Enforcement Administration has scheduled a 10-day hearing for rulemaking related to the potential ban of two psychedelic compounds. The...
Anyone wishing to speak at the meeting must register in advance by Tuesday, Sept. 3 on the FDA website. The U.S. Food and Drug Administration has...
Psilera’s psilocybin drug is non-hallucinogenic. Psilera Inc. reported positive results in initial studies of its non-hallucinogenic psilocybin drug that it plans to use in dementia treatments....
Clearmind Medicine Inc. (Nasdaq: CMND) announced that it has received a new patent approval from the United States Patent and Trademark Office (USPTO) for its proprietary...
Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF) reported the close of its non-brokered private placement, previously announced on August 7, 2024 and updated on August 13,...
MindBio says its studies are funded into 2025. MindBio Therapeutics Corp. (CSE:MBIO) reported durability data from its Phase 2A clinical trials in depressed patients testing MB22001,...
The new rules include licensing procedures for mushroom growers and other business types and sets strict serving limits. The Colorado state government put the finishing touches...
California-based Lykos Therapeutics announced a reorganization plan in the wake of the federal government’s rejection of its application for its MDMA-based drug designed to treat post-traumatic...
